Cilengitide trifluoroacetate

CAS No. 199807-35-7

Cilengitide trifluoroacetate( EMD 121974 | NSC 707544 )

Catalog No. M19460 CAS No. 199807-35-7

Cilengitide is a potent integrin inhibitor for αvβ3 receptor and αvβ5 receptor with IC50 of 4.1 nM and 79 nM in cell-free assays respectively; ~10-fold selectivity against gpIIbIIIa. Phase 2.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Cilengitide trifluoroacetate
  • Note
    Research use only, not for human use.
  • Brief Description
    Cilengitide is a potent integrin inhibitor for αvβ3 receptor and αvβ5 receptor with IC50 of 4.1 nM and 79 nM in cell-free assays respectively; ~10-fold selectivity against gpIIbIIIa. Phase 2.
  • Description
    Cilengitide is a potent integrin inhibitor for αvβ3 receptor and αvβ5 receptor with IC50 of 4.1 nM and 79 nM in cell-free assays respectively; ~10-fold selectivity against gpIIbIIIa. Phase 2.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    EMD 121974 | NSC 707544
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Integrin
  • Recptor
    αvβ3 receptor |αvβ5 receptor
  • Research Area
    Cancer
  • Indication
    Glioblastoma; Head and neck Cancer; Lymphoma; Non-small cell lung Cancer; Prostate Cancer; Solid tumours

Chemical Information

  • CAS Number
    199807-35-7
  • Formula Weight
    702.68
  • Molecular Formula
    C29H41F3N8O9
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:93 mg/mL (132.4 mM);Ethanol:<1 mg/mL;Water:8 mg/mL (11.38 mM)
  • SMILES
    OC(=O)C(F)(F)F.CC(C)[C@@H]1N(C)C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Nisato RE et al. Angiogenesis 2003 6(2) 105-119.
molnova catalog
related products
  • LXW7

    LXW7 is an octamer disulfide cyclic peptide and αvβ3 integrin ligand, acts as a potent and specific endothelial progenitor cells (EPCs) and endothelial cells (ECs) targeting ligand. LXW7 is a disulfide cyclic octa-peptide (cGRGDdvc) containing unnatural amino acids flanking both sides of the main functional motif.

  • A 286982

    A 286982 is an inhibitor that blocks the integrin-ligand interaction between leukocyte function-associated antigen-1 (LFA-1) and intercellular adhesion molecule-1.

  • CWHM-12

    A novel active RGD peptidomimetic inhibitor of αv integrin with IC50s of 1.8/0.8/61/1.5/0.2 nM for αvβ1/αvβ3/αvβ5/αvβ6/αvβ8; no inhibition on αIIbβ3, α2β1 and α10β1 (>50 uM).